Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsukasa Higashionna

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Diagnostic Microbiology and Infectious Disease|April 27, 2025
Gaps between the days of antibiotic spectrum coverage (DASC) and clinical sense of antimicrobial spectrumTsukasa Higashionna, Yohei Manabe, Hideharu Hagiya
The New Microbiologica|January 22, 2024
In vitro Activity of Cefmetazole and Flomoxef among Extended-Spectrum Beta-Lactamase producing EnterobacteralesKoji Iio, Hideharu Hagiya, Tsukasa Higashionna, et al.
Global Health & Medicine|May 3, 2021
COVID-19 in Okayama Prefecture: Looking back and looking forwardHirokazu Tsukahara, Tsukasa Higashionna, Mitsuru Tsuge, et al.
Internal Medicine (Tokyo, Japan)|October 26, 2022
Antimicrobials in the Hospital Are Unevenly Discontinued on WeekdaysHideharu Hagiya, Mika Uno, Tsukasa Higashionna, et al.
Acta Medica Okayama|May 3, 2022
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung CancerTsukasa Higashionna, Soichiro Ushio, Satoru Esumi, et al.
Geriatrics & Gerontology International|June 24, 2022
Trends in places and causes of death among centenarians in Japan from 2006 to 2016Toshihiro Koyama, Tsukasa Higashionna, Akinori Maruo, et al.
JACC. Cardiooncology|September 12, 2025
Risk of Heart Failure Hospitalization in Patients Treated With Osimertinib: A Population-Based Retrospective Cohort StudyYasuhisa Tatebe, Yuta Tanaka, Yohei Manabe, et al.
Oncotarget|July 24, 2018
Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancerEiki Ichihara, Katsuyuki Hotta, Toshio Kubo, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 30, 2022
Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in JapanTakumi Fujimori, Hideharu Hagiya, Koji Iio, et al.
Leukemia Research|April 19, 2026
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBaseJun Matsumoto, Tatsuaki Takeda, Shiho Sugimoto, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Diagnostic Microbiology and Infectious Disease|April 27, 2025
Gaps between the days of antibiotic spectrum coverage (DASC) and clinical sense of antimicrobial spectrumTsukasa Higashionna, Yohei Manabe, Hideharu Hagiya
The New Microbiologica|January 22, 2024
In vitro Activity of Cefmetazole and Flomoxef among Extended-Spectrum Beta-Lactamase producing EnterobacteralesKoji Iio, Hideharu Hagiya, Tsukasa Higashionna, et al.
Global Health & Medicine|May 3, 2021
COVID-19 in Okayama Prefecture: Looking back and looking forwardHirokazu Tsukahara, Tsukasa Higashionna, Mitsuru Tsuge, et al.
Internal Medicine (Tokyo, Japan)|October 26, 2022
Antimicrobials in the Hospital Are Unevenly Discontinued on WeekdaysHideharu Hagiya, Mika Uno, Tsukasa Higashionna, et al.
Acta Medica Okayama|May 3, 2022
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung CancerTsukasa Higashionna, Soichiro Ushio, Satoru Esumi, et al.
Geriatrics & Gerontology International|June 24, 2022
Trends in places and causes of death among centenarians in Japan from 2006 to 2016Toshihiro Koyama, Tsukasa Higashionna, Akinori Maruo, et al.
JACC. Cardiooncology|September 12, 2025
Risk of Heart Failure Hospitalization in Patients Treated With Osimertinib: A Population-Based Retrospective Cohort StudyYasuhisa Tatebe, Yuta Tanaka, Yohei Manabe, et al.
Oncotarget|July 24, 2018
Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancerEiki Ichihara, Katsuyuki Hotta, Toshio Kubo, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 30, 2022
Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in JapanTakumi Fujimori, Hideharu Hagiya, Koji Iio, et al.
Leukemia Research|April 19, 2026
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBaseJun Matsumoto, Tatsuaki Takeda, Shiho Sugimoto, et al.
Pageof 2